✨ Free AI Report
Euroapi: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Euroapi
Company Research

Euroapi: Business Overview, Financials & Competitive Analysis

Euroapi scores 6/10 on the AskCyborg Cyborg Score (Solid). A well-positioned consolidation play in European pharmaceutical manufacturing with exposure to supply chain diversification trends, though margins and market volatility present risks. Euroapi operates in a resilient pharmaceutical supply segment with strategic importance for European healthcare independence. However, the company faces significant competition from established players and integration challenges post-Sanofi spinoff.

What is Euroapi's industry? Euroapi (euroapi.com) operates in Pharmaceutical Manufacturing - Active Pharmaceutical Ingredients. AskCyborg classifies Euroapi under Pharmaceutical Manufacturing - Active Pharmaceutical Ingredients in its company registry.

Euroapi is a European pharmaceutical company specializing in active pharmaceutical ingredients (APIs) and finished dosage forms. Spun off from Sanofi in 2023, it serves as a critical supplier to pharmaceutical manufac...

6/ 10Solid

Cyborg Score thesis

A well-positioned consolidation play in European pharmaceutical manufacturing with exposure to supply chain diversification...

Read the full analyst-debate transcript →
Industry Pharmaceutical Manufacturing - Active Pharmaceutical Ingredients
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Euroapi Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Euroapi

AskCyborg analysts argue the bull and bear cases for Euroapi across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Euroapi OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Euroapi Overview

Pro stress-test →

Euroapi is a European pharmaceutical company specializing in active pharmaceutical ingredients (APIs) and finished dosage forms. Spun off from Sanofi in 2023, it serves as a critical supplier to pharmaceutical manufacturers across Europe and globally.

Strategic Profile

Pro stress-test →

The company positions itself as an independent API and pharmaceutical manufacturer, leveraging operational expertise and capacity across multiple European facilities. Euroapi targets customers seeking diversified supply chains and alternative sources beyond major integrated pharmaceutical players.

Competitive Landscape

Pro stress-test →

Euroapi competes with integrated pharmaceutical companies (Sanofi, GSK), specialized API manufacturers (Albemarle, Cambrex), and emerging competitors in India and China. The company differentiates through European location, regulatory compliance, and established supply relationships.

Industry Context

Euroapi operates in Pharmaceutical Manufacturing - Active Pharmaceutical Ingredients.

Key facts

Founded: 2023 · Headquarters: Lisses, France · Employees: 6,500 · Revenue: $2.2B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Euroapi.

  • Critical role in European pharmaceutical supply chain resilience and healthcare security
  • Spun off from Sanofi with established manufacturing capacity and customer relationships
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • 2023IPO on Euronext Paris following Sanofi spinoff
  • 2024Focus on operational integration and cost optimization post-spinoff
  • +1 moreTrack every material event for Euroapi as it happens. Explore monitoring →
Get alerted when Euroapi has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Active Pharmaceutical IngredientsParent company - integrated pharma manufacturer→Specialty APIsContract development and manufacturing organization→Pharmaceutical ManufacturingSpecialty chemicals and pharma ingredients→

Compare Euroapi with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Euroapi operates in Pharmaceutical Manufacturing - Active Pharmaceutical Ingredients. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Manufacturing - Active Pharmaceutical Ingredients research →
NEW · MCP server

Ask your AI assistant about Euroapi

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Euroapi and its top competitor on Cyborg Score”
“What did Euroapi do this quarter?”
“Is Euroapi a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Euroapi do?+
Euroapi is a European pharmaceutical company specializing in active pharmaceutical ingredients (APIs) and finished dosage forms. Spun off from Sanofi in 2023, it serves as a critical supplier to pharmaceutical manufac...
What is Euroapi's Cyborg Score?+
Euroapi has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Euroapi's main competitors?+
Named competitors include Active Pharmaceutical Ingredients, Specialty APIs, Pharmaceutical Manufacturing. The full competitive landscape is in the AskCyborg report.
How can I get the full Euroapi research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Euroapi research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Euroapi over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.